COVID-19 vaccines have been developed at an unprecedented rate. Over 50 vaccines are in human trials. Several vaccines have received emergency / limited authorization for use in several countries. Several countries have commenced vaccination of priority groups, and many more are expected to commence in coming months. Almost all countries are in the process of procuring, approving and planning their distribution and administration of vaccine. Meanwhile many vaccine candidates continue to be developed and tested.
On a country-by-country basis, MedAire through its group International SOS is continuing to identify the additional support that can be provided to our customers in facilitating, within the rules established by the national authorities, vaccine access, its distribution and/or the vaccination of the employees for our clients. Such support ensures the “readiness” of employers once relevant vaccine(s) become available in a given location. This overview includes all vaccines in Phases 2/3, Phase 3 and Phase 4 trials.
